SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Riot Platforms, Inc. (RIOT) (CIK 0001167419) (RIOT) — Jun 10, 2011

Riot Platforms, Inc. (RIOT) (CIK 0001167419)
Date: June 10, 2011 · CIK: 0001167419 · Accession: 0000000000-11-035788

AI Filing Summary & Sentiment

File numbers found in text: 001-33675

Date
June 10, 2011
Author
Not clearly detected
Form
UPLOAD
Company
Riot Platforms, Inc. (RIOT) (CIK 0001167419)

Letter

June 10, 2011 Stephen T. Lundy Chief Executive Officer and President AspenBio Pharma, Inc. 1585 S. Perry Street Castle Rock, Colorado 80104 Re: AspenBio Pharma, Inc. Preliminary Proxy Statement Filed June 1, 2011 File No. 001-33675

Dear Mr. Lundy: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely,

Jeffrey P. Riedler Assistant Director

Show Raw Text
June 10, 2011
 Stephen T. Lundy Chief Executive Officer and President AspenBio Pharma, Inc. 1585 S. Perry Street Castle Rock, Colorado 80104
 Re: AspenBio Pharma, Inc.
  Preliminary Proxy Statement
 Filed June 1, 2011   File No. 001-33675

Dear Mr. Lundy:
We have completed our review of your f iling.  We remind you that our comments or
changes to disclosure in res ponse to our comments do not for eclose the Commission from taking
any action with respect to the company or th e filing and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States.  We urge all pers ons who are responsible for the
accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.
 Sincerely,

Jeffrey P. Riedler Assistant Director